Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2025-12-25 @ 9:49 PM
Study NCT ID:
NCT00416351
Status:
COMPLETED
Last Update Posted:
2022-05-17
First Post:
2006-12-27
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-06-27
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-03-01
Completion Date Type:
ACTUAL
First Submit Date:
2006-12-27
First Submit QC Date:
None
Study First Post Date:
2006-12-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-01-31
Results First Submit QC Date:
None
Results First Post Date:
2022-05-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-25
Last Update Post Date:
2022-05-17
Last Update Post Date Type:
ACTUAL